RAFAEL MARÍA
CANTÓN MORENO
Profesor asociado
Hospital Virgen de la Arrixaca
Murcia, EspañaPublications en collaboration avec des chercheurs de Hospital Virgen de la Arrixaca (16)
2023
-
Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view
Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 65-81
-
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Frontiers in Microbiology, Vol. 14
2018
-
Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy
Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100
2017
-
Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
-
Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period
mBio, Vol. 8, Núm. 5
2016
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365
-
Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680
2015
-
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Archivos de Bronconeumologia, Vol. 51, Núm. 3, pp. 140-150
2014
-
Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: Towards standard of care practices
BMC Microbiology, Vol. 14, Núm. 1
2013
-
Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: Systematic review of randomised controlled trials
Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 9, pp. 1135-1149
2010
-
Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
2005
-
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972